Galapagos NV
GLPG
$27.82
Share price
1.31%
Change (1 day)
-32.74%
Change (1 year)
Categories
Market capitalization of Galapagos NV (GLPG)
Market cap: $1.83 Billion
As of June 2024 Galapagos NV has a market cap of $1.83 Billion. This makes Galapagos NV the world's 4266th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Galapagos NV from 2008 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.83 B | -31.56% |
| 2023 | $2.67 B | -8.32% |
| 2022 | $2.92 B | -20.02% |
| 2021 | $3.65 B | -43.58% |
| 2020 | $6.47 B | -52.07% |
| 2019 | $13.50 B | 169.16% |
| 2018 | $5.01 B | 4.51% |
| 2017 | $4.80 B | 61.16% |
| 2016 | $2.97 B | 20.89% |
| 2015 | $2.46 B | 331.92% |
| 2014 | $0.57 B | -8.94% |
| 2013 | $0.62 B | 10.91% |
| 2012 | $0.56 B | 58.44% |
| 2011 | $0.35 B | -16.16% |
| 2010 | $0.42 B | 66.9% |
| 2009 | $0.25 B | 148.04% |
| 2008 | $0.10 B |
End of Day market cap according to different sources
On May 31st, 2024 the market cap of Galapagos NV was reported to be:
$1.83 Billion
$1.83 Billion
$1.83 Billion
$1.83 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $352.98 B | 19,154.68% | 🇺🇸 USA |
 Abbott Laboratories ABT | $177.77 B | 9,597.10% | 🇺🇸 USA |
 AbbVie ABBV | $284.72 B | 15,431.31% | 🇺🇸 USA |
 Sanofi SNY | $122.54 B | 6,584.55% | 🇫🇷 France |
 Merck MRK | $317.96 B | 17,244.48% | 🇺🇸 USA |
 AstraZeneca AZN | $241.89 B | 13,095.02% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $93.92 B | 5,023.31% | 🇬🇧 UK |
 Fortress Biotech
FBIO | $36.64 M | -98.00% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $19.17 B | 945.98% | 🇮🇱 Israel |